ResQFoam
Abdominal Hemorrhage Control (Trauma)
Clinical Trial (IDE Approved)Active
Key Facts
Indication
Abdominal Hemorrhage Control (Trauma)
Phase
Clinical Trial (IDE Approved)
Status
Active
Company
About Arsenal Medical
Arsenal Medical leverages a proprietary biomaterials platform to create transformative medical devices for critical care in neurovascular and trauma settings. Its lead programs include ResQFoam, an FDA Breakthrough Device for abdominal hemorrhage control, and NeoCast, an injectable material for deep neurovascular occlusion, which has completed a First-in-Human study. The company is backed by prestigious scientific founders, a seasoned management team, and has secured significant non-dilutive funding from government agencies, positioning it to advance its pipeline through clinical development.
View full company profile